TIL Therapies market 2022 – Industry Growth by 2035 Given the limitations associated with conventional cancer treatment options, there has been a surge in the need for more effective, safe and versatile alternatives, such as TIL-based therapies. Driven by a promising development pipeline and encouraging clinical trial results, the TIL-based therapy market is likely to carve out a significant share of the cancer immunotherapy market. The financial opportunity within the TIL-based therapy market has been analyzed across the following segments:  Target Indication(s)  Melanoma  Head and Neck Carcinoma  Chronic Lymphocytic Leukemia  Sarcoma  Hepatocellular Carcinoma  Breast Cancer  Acute Myeloid Leukemia  Cervical Carcinoma  Key Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa  Rest of the World The Global TIL Therapy Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:  Cellectis  Cellular Biomedicine Group  Iovance Biotherapeutics  Lytix Biopharma  Phio Pharmaceuticals Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. TIL-based Therapies: Market Landscape 5. Clinical Trial Analysis 6. Key Opinion Leaders 7. TIL-based Therapy Profiles 8. Partnerships And Collaborations 9. Funding And Investment Analysis 10. Patent Analysis 11. Case Study: Cell Therapy Manufacturing 12. Cost Price Analysis 13. Market Forecast and Opportunity Analysis 14. Company Profiles 15. Concluding Remarks 16. Executive Insights 17. Appendix I: Tabulated Data 18. Appendix II: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/til-therapies-market.html You may also be interested in the following titles: Decentralized Clinical Trials / Virtual Clinical Trials Market Global Antibiotics Market You may also like to learn what our experts are sharing in Roots educational series: Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #TIL-basedtherapies #TumorInfiltratingLymphocyteReceptor #TIL #MarketResearch #MarketInsights

Manufacturing execution systems market Research Report by 2022, Forecast till 2035 Rising complexities related to huge data volumes being generated in the healthcare sector, along with the need for visibility, control and synchronization in production processes, has prompted players in the healthcare market to integrate manufacturing execution systems Driven by the ongoing innovation in the healthcare industry, as well as the rise in the demand for automated solutions in order to connect, monitor and control the complex production process, the MES providers market for the healthcare sector is likely to witness positive growth over the coming years. It is worth highlighting that, players are integrating advanced technologies, including internet of thing (IoT) and artificial intelligence (AI), in order to collect and analyze large volumes of data from various sources, as well as to produce value in the form of insights, predictions and actions. The financial opportunity within the manufacturing execution system providers in healthcare market has been analyzed across the following segments:  Type of Deployment  Cloud  Corporate Datacenter  Hybrid  On Premise  Type of End User  Life science / Biotechnology Companies  Medical Device Providers  Pharmaceutical Companies  Others  Key Geographical Regions  North America  Europe  Asia  Middle East and North Africa  Latin America  Rest of the World The “Manufacturing Execution System Market, 2022-2035” report the following companies, which we identified to be key players in this domain:  Andea  Critical Manufacturing  Dassault Systèmes  GE Digital  Infor  Körber  Rockwell Automation Table of Contents Background Executive Summary Introduction Market Landscape Key Insights Partnerships and Collaborations Company Competitiveness Analysis Company Profiles Value Creation Framework: A Strategic Guide to Address Unmet Need For Manufacturing Execution Systems Market Forecast Appendix I: Other Figures Appendix II: Tabulated Data Appendix III: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/manufacturing-execution-systems-market.html You may also be interested in the following titles: Global Antibiotics Market Pharmaceutical Polymers / Medical Polymers Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #ManufacturingexecutionsystemsMarket #mes #manufacturingexecutionsystems #MarketResearch #MarketInsights